SARS-CoV-2 Mpro oligomerization as a potential target for therapy.

Lis K, Plewka J, Menezes F, Bielecka E, Chykunova Y, Pustelny K, Niebling S, Garcia AS, Garcia-Alai M, Popowicz GM, Czarna A, Kantyka T, Pyrc K

International journal of biological macromolecules, 2024

doi:10.1016/j.ijbiomac.2024.131392.